ESR2 and atherosclerosis: Next, we aimed to investigate whether the observed changes in the expression of molecules implicated in the advanced stages of the atherosclerosis process upon treatment with E2 were mediated through Erα-, Erβ-, or GPR-30-dependent pathways.